Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-03

AUTHORS

A Rager, N Frey, S C Goldstein, R Reshef, E O Hexner, A Loren, S M Luger, A Perl, D Tsai, J Davis, M Vozniak, J Smith, E A Stadtmauer, D L Porter

ABSTRACT

Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-α are important mediators of GVHD and may be critical targets for therapy. We retrospectively reviewed our experience using combination anti-cytokine therapy of daclizumab and infliximab. Seventeen evaluable patients had a median age of 47 years (range 35-63). The conditioning regimen was myeloablative in 13 and non-myeloablative in 4 cases. GVHD occurred at a median of 49 days after transplant in 12 patients (range 21-231 days) and at a median of 46 days (range 25-119 days) after donor lymphocyte infusion in 5 patients. All patients had persistent or progressive GVHD despite 1-2 mg/kg/day of corticosteroids for a median of 7 days (range 2-26 days). They received a combination of daclizumab and infliximab for acute GVHD IBMTR severity index B (3), C (10) or D (4). Of the 17 patients analyzed, 47% responded to treatment, 24% had complete resolution of symptoms and 24% had partial responses. Survival was limited and all the patients died a median of 6.7 months (range 1.6-26) from transplant and 35 days from initiation of daclizumab/infliximab. This retrospective analysis suggests that combination anti-cytokine therapy with daclizumab/infliximab has significant activity in SR-GVHD, but outcomes remain poor. New methods to prevent and treat GVHD are urgently needed. More... »

PAGES

430

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2010.117

DOI

http://dx.doi.org/10.1038/bmt.2010.117

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001461507

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20498647


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulin G", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunosuppressive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infliximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Steroids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rager", 
        "givenName": "A", 
        "id": "sg:person.01212723440.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212723440.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frey", 
        "givenName": "N", 
        "id": "sg:person.01342471137.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342471137.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldstein", 
        "givenName": "S C", 
        "id": "sg:person.016115210252.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reshef", 
        "givenName": "R", 
        "id": "sg:person.01267452463.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267452463.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hexner", 
        "givenName": "E O", 
        "id": "sg:person.01157065163.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157065163.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loren", 
        "givenName": "A", 
        "id": "sg:person.0613365041.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613365041.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Luger", 
        "givenName": "S M", 
        "id": "sg:person.012415664717.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012415664717.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perl", 
        "givenName": "A", 
        "id": "sg:person.0661500241.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661500241.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsai", 
        "givenName": "D", 
        "id": "sg:person.012706202757.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012706202757.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "J", 
        "id": "sg:person.0656420024.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656420024.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vozniak", 
        "givenName": "M", 
        "id": "sg:person.0724533224.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724533224.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "J", 
        "id": "sg:person.01004225563.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004225563.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stadtmauer", 
        "givenName": "E A", 
        "id": "sg:person.01044042041.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Penn Presbyterian Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412713.2", 
          "name": [
            "Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Porter", 
        "givenName": "D L", 
        "id": "sg:person.0707416147.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1997.1112925.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000437859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.1997.1112925.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000437859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-03-212290", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001611407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/bbmt.2002.v8.pm12171485", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005360009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.20648", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007210230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pbc.20648", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007210230"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e31819daf60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007688274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e31819daf60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007688274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mph.0b013e31819daf60", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007688274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2005.05631.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008546660"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1703094", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011191594", 
          "https://doi.org/10.1038/sj.bmt.1703094"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-03-0854", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012449632"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-12-041889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013110333"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705762", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013865482", 
          "https://doi.org/10.1038/sj.bmt.1705762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2006.06321.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014592689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/bbmt.2002.v8.pm11939605", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018269103"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2004.04856.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021868023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-11-4513", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022078117"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-01-0267", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024061987"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2009.05.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036851953"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1703032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040041491", 
          "https://doi.org/10.1038/sj.bmt.1703032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.2001.02582.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043256517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1704929", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045806031", 
          "https://doi.org/10.1038/sj.bmt.1704929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2004.07.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046073242"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02983793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047623985", 
          "https://doi.org/10.1007/bf02983793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02983793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047623985", 
          "https://doi.org/10.1007/bf02983793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2003-12-4241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052535770"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074566056", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076843321", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076963175", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078048643", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078474336", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078628577", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082422699", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-03", 
    "datePublishedReg": "2011-03-01", 
    "description": "Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-\u03b1 are important mediators of GVHD and may be critical targets for therapy. We retrospectively reviewed our experience using combination anti-cytokine therapy of daclizumab and infliximab. Seventeen evaluable patients had a median age of 47 years (range 35-63). The conditioning regimen was myeloablative in 13 and non-myeloablative in 4 cases. GVHD occurred at a median of 49 days after transplant in 12 patients (range 21-231 days) and at a median of 46 days (range 25-119 days) after donor lymphocyte infusion in 5 patients. All patients had persistent or progressive GVHD despite 1-2\u2009mg/kg/day of corticosteroids for a median of 7 days (range 2-26 days). They received a combination of daclizumab and infliximab for acute GVHD IBMTR severity index B (3), C (10) or D (4). Of the 17 patients analyzed, 47% responded to treatment, 24% had complete resolution of symptoms and 24% had partial responses. Survival was limited and all the patients died a median of 6.7 months (range 1.6-26) from transplant and 35 days from initiation of daclizumab/infliximab. This retrospective analysis suggests that combination anti-cytokine therapy with daclizumab/infliximab has significant activity in SR-GVHD, but outcomes remain poor. New methods to prevent and treat GVHD are urgently needed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bmt.2010.117", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2420935", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "46"
      }
    ], 
    "name": "Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD", 
    "pagination": "430", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "06f63e2ed9815802c4b3e15df4dbe624deafa18d9e911f455d1058031ee6eda7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20498647"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2010.117"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001461507"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2010.117", 
      "https://app.dimensions.ai/details/publication/pub.1001461507"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000436.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bmt2010117"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.117'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.117'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.117'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2010.117'


 

This table displays all metadata directly associated to this object as RDF triples.

322 TRIPLES      21 PREDICATES      77 URIs      39 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2010.117 schema:about N0e4f116733644303abe62ff3089166e9
2 N1baa4e99fbdc42f3b937758a70d6adf8
3 N203161e5bbe34553908542acef50d476
4 N20ac793594b94f88bcad1e8d4c8e9e07
5 N287b16cfdbad456da9bd0ba6af5f0e95
6 N492019af3f8647d8a13d3294a0e2c9c3
7 N5c287d2eda7b4e1983b4287aa831d0ce
8 N62ad8525644c4286a4d16b0798dbbcdf
9 N69e91a4bf60b4736a0db7ffd500a9938
10 N752e61b02dc04010b1ad8972c35dd728
11 N80f4d00c998147428091d7e8df1cabfd
12 N821692e593bb4f47bc0f9c4610e5d006
13 N83c11e484a9c473baf80db720e9ef76c
14 N9d481392822c42b4823e8cddfc903fba
15 Nbf21a391a8d548409f452b7c99f2828d
16 Nc7e0c81c215149339cf759638bea8f1f
17 Ndbb7bedd39a14e76afb041c1c2f13858
18 Ne0d0dbc91ee34607ab722732dabc5828
19 anzsrc-for:11
20 anzsrc-for:1103
21 schema:author N2afc179e057c4b1dbf514cc7c21c35e1
22 schema:citation sg:pub.10.1007/bf02983793
23 sg:pub.10.1038/sj.bmt.1703032
24 sg:pub.10.1038/sj.bmt.1703094
25 sg:pub.10.1038/sj.bmt.1704929
26 sg:pub.10.1038/sj.bmt.1705762
27 https://app.dimensions.ai/details/publication/pub.1074566056
28 https://app.dimensions.ai/details/publication/pub.1076843321
29 https://app.dimensions.ai/details/publication/pub.1076963175
30 https://app.dimensions.ai/details/publication/pub.1078048643
31 https://app.dimensions.ai/details/publication/pub.1078474336
32 https://app.dimensions.ai/details/publication/pub.1078628577
33 https://app.dimensions.ai/details/publication/pub.1082422699
34 https://doi.org/10.1002/pbc.20648
35 https://doi.org/10.1016/j.bbmt.2004.07.007
36 https://doi.org/10.1016/j.bbmt.2009.05.019
37 https://doi.org/10.1046/j.1365-2141.1997.1112925.x
38 https://doi.org/10.1046/j.1365-2141.2001.02582.x
39 https://doi.org/10.1053/bbmt.2002.v8.pm11939605
40 https://doi.org/10.1053/bbmt.2002.v8.pm12171485
41 https://doi.org/10.1080/01621459.1958.10501452
42 https://doi.org/10.1097/mph.0b013e31819daf60
43 https://doi.org/10.1111/j.1365-2141.2004.04856.x
44 https://doi.org/10.1111/j.1365-2141.2005.05631.x
45 https://doi.org/10.1111/j.1365-2141.2006.06321.x
46 https://doi.org/10.1182/blood-2003-01-0267
47 https://doi.org/10.1182/blood-2003-12-4241
48 https://doi.org/10.1182/blood-2004-03-0854
49 https://doi.org/10.1182/blood-2004-11-4513
50 https://doi.org/10.1182/blood-2006-12-041889
51 https://doi.org/10.1182/blood-2009-03-212290
52 schema:datePublished 2011-03
53 schema:datePublishedReg 2011-03-01
54 schema:description Treatment options for steroid-refractory GVHD (SR-GVHD) are unsatisfactory and prognosis is poor. Inflammatory cytokines IL-2 and TNF-α are important mediators of GVHD and may be critical targets for therapy. We retrospectively reviewed our experience using combination anti-cytokine therapy of daclizumab and infliximab. Seventeen evaluable patients had a median age of 47 years (range 35-63). The conditioning regimen was myeloablative in 13 and non-myeloablative in 4 cases. GVHD occurred at a median of 49 days after transplant in 12 patients (range 21-231 days) and at a median of 46 days (range 25-119 days) after donor lymphocyte infusion in 5 patients. All patients had persistent or progressive GVHD despite 1-2 mg/kg/day of corticosteroids for a median of 7 days (range 2-26 days). They received a combination of daclizumab and infliximab for acute GVHD IBMTR severity index B (3), C (10) or D (4). Of the 17 patients analyzed, 47% responded to treatment, 24% had complete resolution of symptoms and 24% had partial responses. Survival was limited and all the patients died a median of 6.7 months (range 1.6-26) from transplant and 35 days from initiation of daclizumab/infliximab. This retrospective analysis suggests that combination anti-cytokine therapy with daclizumab/infliximab has significant activity in SR-GVHD, but outcomes remain poor. New methods to prevent and treat GVHD are urgently needed.
55 schema:genre research_article
56 schema:inLanguage en
57 schema:isAccessibleForFree true
58 schema:isPartOf N9a6ab95ff91e4605988720b7c05cd8b1
59 Nfbf7a56ebbef4bd9ba35d4d84a9dd5b9
60 sg:journal.1096890
61 schema:name Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD
62 schema:pagination 430
63 schema:productId N31729027d9fd4e3bae2d0381f684c970
64 N9a77c4d56f4645008f65f60ede83fa47
65 Nbb20b7aebf7b47f1b9734991cdfb43de
66 Ncc2cee991b794762ae85a77323b0b49e
67 Nde4453059e1340dc9092d0310cfa8672
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001461507
69 https://doi.org/10.1038/bmt.2010.117
70 schema:sdDatePublished 2019-04-10T18:09
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N525b8d4cbb2e468d9fb272ff54c6c243
73 schema:url https://www.nature.com/articles/bmt2010117
74 sgo:license sg:explorer/license/
75 sgo:sdDataset articles
76 rdf:type schema:ScholarlyArticle
77 N0995f0157ede4dde88379981048a50dd rdf:first sg:person.012706202757.24
78 rdf:rest N60ca0910fa5e48e1921e2789722ede7a
79 N0e4f116733644303abe62ff3089166e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Middle Aged
81 rdf:type schema:DefinedTerm
82 N1baa4e99fbdc42f3b937758a70d6adf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Antibodies, Monoclonal
84 rdf:type schema:DefinedTerm
85 N203161e5bbe34553908542acef50d476 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Steroids
87 rdf:type schema:DefinedTerm
88 N20ac793594b94f88bcad1e8d4c8e9e07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Adult
90 rdf:type schema:DefinedTerm
91 N27a1e830fa2a49138b5794d2640bb764 rdf:first sg:person.01004225563.72
92 rdf:rest Nbec4cfa24cd040439bb06439cbfc3e0c
93 N287b16cfdbad456da9bd0ba6af5f0e95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Male
95 rdf:type schema:DefinedTerm
96 N2afc179e057c4b1dbf514cc7c21c35e1 rdf:first sg:person.01212723440.81
97 rdf:rest N89151d1e73bf43c095db9a37811601c9
98 N31729027d9fd4e3bae2d0381f684c970 schema:name pubmed_id
99 schema:value 20498647
100 rdf:type schema:PropertyValue
101 N3c09226a7cfa4a6ea25b8ba0aa6d063d rdf:first sg:person.01157065163.51
102 rdf:rest Ne3e5d2db03c346b09182c7d42ea0ed80
103 N3c721265ac444ea39e6c4821d52aafb1 rdf:first sg:person.0707416147.15
104 rdf:rest rdf:nil
105 N492019af3f8647d8a13d3294a0e2c9c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Graft vs Host Disease
107 rdf:type schema:DefinedTerm
108 N525b8d4cbb2e468d9fb272ff54c6c243 schema:name Springer Nature - SN SciGraph project
109 rdf:type schema:Organization
110 N5c287d2eda7b4e1983b4287aa831d0ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Immunosuppressive Agents
112 rdf:type schema:DefinedTerm
113 N60ca0910fa5e48e1921e2789722ede7a rdf:first sg:person.0656420024.61
114 rdf:rest Nadbde913449042e1895d9537468c343e
115 N62ad8525644c4286a4d16b0798dbbcdf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Survival Analysis
117 rdf:type schema:DefinedTerm
118 N69e91a4bf60b4736a0db7ffd500a9938 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Humans
120 rdf:type schema:DefinedTerm
121 N752e61b02dc04010b1ad8972c35dd728 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Drug Resistance
123 rdf:type schema:DefinedTerm
124 N80f4d00c998147428091d7e8df1cabfd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Retrospective Studies
126 rdf:type schema:DefinedTerm
127 N821692e593bb4f47bc0f9c4610e5d006 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Prognosis
129 rdf:type schema:DefinedTerm
130 N83c11e484a9c473baf80db720e9ef76c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Female
132 rdf:type schema:DefinedTerm
133 N89151d1e73bf43c095db9a37811601c9 rdf:first sg:person.01342471137.57
134 rdf:rest N8a556bbd1d5349a5947d82e54fa7e415
135 N8a556bbd1d5349a5947d82e54fa7e415 rdf:first sg:person.016115210252.03
136 rdf:rest Nf4204811af134b29935d7146bc69caf3
137 N9a6ab95ff91e4605988720b7c05cd8b1 schema:volumeNumber 46
138 rdf:type schema:PublicationVolume
139 N9a77c4d56f4645008f65f60ede83fa47 schema:name dimensions_id
140 schema:value pub.1001461507
141 rdf:type schema:PropertyValue
142 N9ca7a00174234d5aaaf6649d0e2d436d rdf:first sg:person.0661500241.33
143 rdf:rest N0995f0157ede4dde88379981048a50dd
144 N9d481392822c42b4823e8cddfc903fba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Acute Disease
146 rdf:type schema:DefinedTerm
147 Na1386520d8e040f0b954402dfc9cd329 rdf:first sg:person.012415664717.68
148 rdf:rest N9ca7a00174234d5aaaf6649d0e2d436d
149 Nadbde913449042e1895d9537468c343e rdf:first sg:person.0724533224.87
150 rdf:rest N27a1e830fa2a49138b5794d2640bb764
151 Nbb20b7aebf7b47f1b9734991cdfb43de schema:name nlm_unique_id
152 schema:value 8702459
153 rdf:type schema:PropertyValue
154 Nbec4cfa24cd040439bb06439cbfc3e0c rdf:first sg:person.01044042041.97
155 rdf:rest N3c721265ac444ea39e6c4821d52aafb1
156 Nbf21a391a8d548409f452b7c99f2828d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Treatment Outcome
158 rdf:type schema:DefinedTerm
159 Nc7e0c81c215149339cf759638bea8f1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Immunoglobulin G
161 rdf:type schema:DefinedTerm
162 Ncc2cee991b794762ae85a77323b0b49e schema:name readcube_id
163 schema:value 06f63e2ed9815802c4b3e15df4dbe624deafa18d9e911f455d1058031ee6eda7
164 rdf:type schema:PropertyValue
165 Ndbb7bedd39a14e76afb041c1c2f13858 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Antibodies, Monoclonal, Humanized
167 rdf:type schema:DefinedTerm
168 Nde4453059e1340dc9092d0310cfa8672 schema:name doi
169 schema:value 10.1038/bmt.2010.117
170 rdf:type schema:PropertyValue
171 Ne0d0dbc91ee34607ab722732dabc5828 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Infliximab
173 rdf:type schema:DefinedTerm
174 Ne3e5d2db03c346b09182c7d42ea0ed80 rdf:first sg:person.0613365041.61
175 rdf:rest Na1386520d8e040f0b954402dfc9cd329
176 Nf4204811af134b29935d7146bc69caf3 rdf:first sg:person.01267452463.62
177 rdf:rest N3c09226a7cfa4a6ea25b8ba0aa6d063d
178 Nfbf7a56ebbef4bd9ba35d4d84a9dd5b9 schema:issueNumber 3
179 rdf:type schema:PublicationIssue
180 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
181 schema:name Medical and Health Sciences
182 rdf:type schema:DefinedTerm
183 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
184 schema:name Clinical Sciences
185 rdf:type schema:DefinedTerm
186 sg:grant.2420935 http://pending.schema.org/fundedItem sg:pub.10.1038/bmt.2010.117
187 rdf:type schema:MonetaryGrant
188 sg:journal.1096890 schema:issn 0268-3369
189 1476-5365
190 schema:name Bone Marrow Transplantation
191 rdf:type schema:Periodical
192 sg:person.01004225563.72 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
193 schema:familyName Smith
194 schema:givenName J
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004225563.72
196 rdf:type schema:Person
197 sg:person.01044042041.97 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
198 schema:familyName Stadtmauer
199 schema:givenName E A
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97
201 rdf:type schema:Person
202 sg:person.01157065163.51 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
203 schema:familyName Hexner
204 schema:givenName E O
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01157065163.51
206 rdf:type schema:Person
207 sg:person.01212723440.81 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
208 schema:familyName Rager
209 schema:givenName A
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212723440.81
211 rdf:type schema:Person
212 sg:person.012415664717.68 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
213 schema:familyName Luger
214 schema:givenName S M
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012415664717.68
216 rdf:type schema:Person
217 sg:person.01267452463.62 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
218 schema:familyName Reshef
219 schema:givenName R
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267452463.62
221 rdf:type schema:Person
222 sg:person.012706202757.24 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
223 schema:familyName Tsai
224 schema:givenName D
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012706202757.24
226 rdf:type schema:Person
227 sg:person.01342471137.57 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
228 schema:familyName Frey
229 schema:givenName N
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342471137.57
231 rdf:type schema:Person
232 sg:person.016115210252.03 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
233 schema:familyName Goldstein
234 schema:givenName S C
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03
236 rdf:type schema:Person
237 sg:person.0613365041.61 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
238 schema:familyName Loren
239 schema:givenName A
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613365041.61
241 rdf:type schema:Person
242 sg:person.0656420024.61 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
243 schema:familyName Davis
244 schema:givenName J
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656420024.61
246 rdf:type schema:Person
247 sg:person.0661500241.33 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
248 schema:familyName Perl
249 schema:givenName A
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661500241.33
251 rdf:type schema:Person
252 sg:person.0707416147.15 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
253 schema:familyName Porter
254 schema:givenName D L
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15
256 rdf:type schema:Person
257 sg:person.0724533224.87 schema:affiliation https://www.grid.ac/institutes/grid.412713.2
258 schema:familyName Vozniak
259 schema:givenName M
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724533224.87
261 rdf:type schema:Person
262 sg:pub.10.1007/bf02983793 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047623985
263 https://doi.org/10.1007/bf02983793
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/sj.bmt.1703032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040041491
266 https://doi.org/10.1038/sj.bmt.1703032
267 rdf:type schema:CreativeWork
268 sg:pub.10.1038/sj.bmt.1703094 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011191594
269 https://doi.org/10.1038/sj.bmt.1703094
270 rdf:type schema:CreativeWork
271 sg:pub.10.1038/sj.bmt.1704929 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045806031
272 https://doi.org/10.1038/sj.bmt.1704929
273 rdf:type schema:CreativeWork
274 sg:pub.10.1038/sj.bmt.1705762 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013865482
275 https://doi.org/10.1038/sj.bmt.1705762
276 rdf:type schema:CreativeWork
277 https://app.dimensions.ai/details/publication/pub.1074566056 schema:CreativeWork
278 https://app.dimensions.ai/details/publication/pub.1076843321 schema:CreativeWork
279 https://app.dimensions.ai/details/publication/pub.1076963175 schema:CreativeWork
280 https://app.dimensions.ai/details/publication/pub.1078048643 schema:CreativeWork
281 https://app.dimensions.ai/details/publication/pub.1078474336 schema:CreativeWork
282 https://app.dimensions.ai/details/publication/pub.1078628577 schema:CreativeWork
283 https://app.dimensions.ai/details/publication/pub.1082422699 schema:CreativeWork
284 https://doi.org/10.1002/pbc.20648 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007210230
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/j.bbmt.2004.07.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046073242
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/j.bbmt.2009.05.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036851953
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1046/j.1365-2141.1997.1112925.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1000437859
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1046/j.1365-2141.2001.02582.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043256517
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1053/bbmt.2002.v8.pm11939605 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018269103
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1053/bbmt.2002.v8.pm12171485 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005360009
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1097/mph.0b013e31819daf60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007688274
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1111/j.1365-2141.2004.04856.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1021868023
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1111/j.1365-2141.2005.05631.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1008546660
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1111/j.1365-2141.2006.06321.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014592689
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1182/blood-2003-01-0267 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024061987
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1182/blood-2003-12-4241 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052535770
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1182/blood-2004-03-0854 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012449632
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1182/blood-2004-11-4513 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022078117
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1182/blood-2006-12-041889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013110333
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1182/blood-2009-03-212290 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001611407
319 rdf:type schema:CreativeWork
320 https://www.grid.ac/institutes/grid.412713.2 schema:alternateName Penn Presbyterian Medical Center
321 schema:name Division of Hematology-Oncology, Blood and Marrow Transplant Program, University of Pennsylvania Medical Center, Philadelphia, PA, USA
322 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...